Showing 1 - 13 of 3,018
View by: Cover Page List Articles
-
Characterizing malignant prognostic signatures in primary glioma based on single-cell and bulk transcriptome sequencing
published 05 Jun 2026
Loading metrics information...
Metrics unavailable. Please check back later.
-
Comprehensive multi-omics analysis reveals prognostic, immune, and therapeutic signatures of TNFAIP family genes in breast cancer
published 29 May 2026
Loading metrics information...
Metrics unavailable. Please check back later.
-
Machine learning-based prediction of hepatocellular carcinoma risk in steatotic liver disease: A nationwide cohort study
published 28 May 2026
Loading metrics information...
Metrics unavailable. Please check back later.
-
Uncovering core stemness biomarkers in HBV-HCC through integrated multi-omics
published 14 May 2026
Loading metrics information...
Metrics unavailable. Please check back later.
-
Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma
published 14 May 2026
Loading metrics information...
Metrics unavailable. Please check back later.
-
Diagnostic performance of abbreviated non-contrast liver MRI for detecting synchronous colorectal liver metastases
published 13 May 2026
Loading metrics information...
Metrics unavailable. Please check back later.
-
A novel application tunnel in combination with medical training reduces stress induced by frequent intraperitoneal injections and blood draws in mice
published 07 May 2026
Loading metrics information...
Metrics unavailable. Please check back later.
-
Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
published 07 May 2026
Loading metrics information...
Metrics unavailable. Please check back later.
-
Unraveling the role of ChREBP in lung adenocarcinoma: Expression, regulatory networks, and potential functional impact
published 30 Apr 2026
Loading metrics information...
Metrics unavailable. Please check back later.
-
Primary liver cancer in Georgia: Seven years’ experience following the launch of the Hepatitis C Elimination Program, 2015–2022
published 28 Apr 2026
Loading metrics information...
Metrics unavailable. Please check back later.
-
Curability difference between autochthonous mouse tumors and their transplants in association with immune gene expression
published 24 Apr 2026
Loading metrics information...
Metrics unavailable. Please check back later.
-
The role of SPP1 in evaluating the prognosis, immune infiltration, and drug sensitivity of hepatocellular carcinoma
published 22 Apr 2026
Loading metrics information...
Metrics unavailable. Please check back later.
-
Higher order synthetic lethals are keys to minimize cancer treatment effects on non-tumor cells
published 15 Apr 2026
Loading metrics information...
Metrics unavailable. Please check back later.
Connect with Us